Page 1 of 62 Diabetes JNK activation of BIM promotes hepatic oxidative stress, steatosis and insulin resistance in obesity. Sara A. Litwak1, Lokman Pang1,2, Sandra Galic1, Mariana Igoillo-Esteve3, William J. Stanley1,2, Jean-Valery Turatsinze3, Kim Loh1, Helen E. Thomas1,2, Arpeeta Sharma4, Eric Trepo5,6, Christophe Moreno5,6, Daniel J. Gough7,8, Decio L. Eizirik3, Judy B. de Haan4, Esteban N. Gurzov1,2,a 1St Vincent’s Institute of Medical Research, Melbourne, Australia. 2Department of Medicine, St. Vincent’s Hospital, The University of Melbourne, Melbourne, Australia. 3ULB Center for Diabetes Research, Université Libre de Bruxelles (ULB), Brussels, Belgium. 4Oxidative Stress Laboratory, Basic Science Division, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia. 5CUB Hôpital Erasme, Université Libre de Bruxelles (ULB), Belgium. 6Laboratory of experimental Gastroenterology, Université Libre de Bruxelles (ULB), Belgium. 7Hudson Institute of Medical Research, Clayton, VIC, Australia. 8Department of Molecular and Translational Science, Monash University, Clayton, Vic, Australia. aPresent address, to where correspondence and reprint requests should be addressed: Dr Esteban N. Gurzov ULB Center for Diabetes Research Université Libre de Bruxelles Campus Erasme, Route de Lennik 808, B-1070-Brussels-Belgium Phone: +32 2 5556242 Fax: +32 2 5556239 Email:
[email protected] Disclosure statement: The authors declare no conflict of interest Running Title: BIM regulates lipid metabolism in hepatocytes. 1 Diabetes Publish Ahead of Print, published online September 19, 2017 Diabetes Page 2 of 62 ABSTRACT The BCL-2 family are crucial regulators of the mitochondrial pathway of apoptosis in normal physiology and disease. Besides their role in cell death, BCL-2 proteins have been implicated in the regulation of mitochondrial oxidative phosphorylation and cellular metabolism.